Search by Drug Name or NDC

    NDC 00093-6031-82 Rivelsa Details

    Rivelsa

    Rivelsa is a KIT in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Teva Pharmaceuticals USA, Inc.. The primary component is .

    Product Information

    NDC 00093-6031
    Product ID 0093-6031_8b3ea105-d75c-4b8c-817d-0424ed11cf22
    Associated GPIs 25993002300350
    GCN Sequence Number 070814
    GCN Sequence Number Description L-norgest/e.estradiol-e.estrad TBDSPK 3MO 0.15MG(84) ORAL
    HIC3 G8A
    HIC3 Description CONTRACEPTIVES,ORAL
    GCN 34465
    HICL Sequence Number 033792
    HICL Sequence Number Description LEVONORGESTREL/ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL
    Brand/Generic Generic
    Proprietary Name Rivelsa
    Proprietary Name Suffix n/a
    Non-Proprietary Name Levonorgestrel/Ethinyl Estradiol and Ethinyl Estradiol
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form KIT
    Route n/a
    Active Ingredient Strength n/a
    Active Ingredient Units n/a
    Substance Name n/a
    Labeler Name Teva Pharmaceuticals USA, Inc.
    Pharmaceutical Class n/a
    DEA Schedule n/a
    Marketing Category NDA AUTHORIZED GENERIC
    Application Number NDA204061
    Listing Certified Through 2024-12-31

    Package

    NDC 00093-6031-82 (00093603182)

    NDC Package Code 0093-6031-82
    Billing NDC 00093603182
    Package 2 POUCH in 1 CARTON (0093-6031-82) / 1 KIT in 1 POUCH (0093-6031-91)
    Marketing Start Date 2017-04-03
    NDC Exclude Flag N
    Pricing Information N/A